2025 Silent Capital Report now available. Where family offices and LPs are actually deploying. [Download for free →]
About usSign in

CrossBorder Impact Ventures

Status
ACTIVE
Global HQ
Toronto, Canada
Countries of investment
  • United States
Investment stages
  • Pre-Seed
  • Seed
  • Series A
  • Series B
Industries
  • Health Tech
About
Cross-Border Impact Ventures is a women-led impact venture capital firm headquartered in Toronto, Canada, dedicated to transforming health outcomes through targeted venture financing. Operating across North America and Europe, the firm combines rigorous impact measurement with specialized healthcare expertise to scale technological breakthroughs in global health and medical diagnostics.
Min check size
$10M
Max check size
$30M
Fund size
NPS

Investment Thesis

Cross-Border Impact Ventures’ investment thesis centers on investing in women-led and innovative early-growth health technology companies that deliver measurable health impacts alongside financial returns. The firm targets solutions improving maternal, newborn, and child health, as well as broader healthcare access across underserved global markets.
Lead investor
Co Invest
Number of exits
Preferred contact method

Manager's Experience

Leveraging extensive experience in the technology and healthcare sectors, the fund manager has successfully executed over 50 deals across North America and Europe. Their investment strategy emphasizes a data-driven approach, allowing for strategic insights that lead to impactful decisions. With a focus on early to growth-stage companies, they have achieved several notable exits, demonstrating a strong capability to identify and nurture high-potential opportunities. Their operator-first philosophy fosters close collaboration with portfolio companies, driving innovation and value creation.

CrossBorder Impact Ventures Contacts Information

Primary contact

Secondary contact

Team

Annie Thériault - Managing Partner

Donna Parr - Managing Partner

Cyriac Alappat - Principal

Megan Dover - Junior Partner

Issy Gordon - Investment Director

Pooja Sikka - Venture Partner

Juanita Cortés - Chief Financial Officer

Hamza Kayani - Investment Analyst

Hannah Sharpe - ESG and Health Impact Associate

Tasha Noronha - Partnerships and Operations Manager

Portfolio

Pendulum

Daye

mOm Incubators

Sonio

OncoLens

Raydiant Oximetry

Axena Health

Oxford Cancer Analytics (OXcan)

Cardiosense

TidalSense. impactalpha

Fund number
Year Founded
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp